Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 808 results for "Treatment For Ovarian Cancer"

Combination Therapy Effective Against Ovarian, Breast Cancer
MedIndia

'Ovarian, breast cancer combo therapy to overcome drug resista...

By Sahana Ghosh Kolkata, Sep 26 (IANS): Bolstering the knowhow behind targeted cancer treatment, Indian scientists have offered a new rationale for combination drug therapy for ovarian and breast cancer, which they say can counter drug resistance ... Daijiworldcom, 4 hours ago
[x]  
Monthly Prescribing Reference

FDA Warning on Ovarian Cancer Screening Test -- Is It Enough?

Hello. I'm Dr Maurie Markman from Cancer Treatment Centers of America in Philadelphia. I want to comment briefly on a new US Food and Drug Administration (FDA) warning regarding claims by a company that they have a test based on a CA 125 algorithm ...
 Dermatology Online Journal17 hours ago FDA: Clinicians May Be Misled by Ovarian Screening Test Claims  Monthly Prescribing Reference1 day ago Abcodia Suspends Sale of Ovarian Cancer Screening Test After FDA Communication  Cancer Letter.com1 week ago

September 27, 2016

9:00 PM PT Ottawa report, ovarian cancer, private care homes, court delays, US debate panel, drug treatment beds,
 CBC18 hours ago
Nanotechnology News

Fighting cancer with sticky nanoparticles

A team of researchers at Yale found that a treatment using bioadhesive nanoparticles loaded with a potent chemotherapy drug proved more effective and less toxic than conventional treatments for gynecological cancer. The results of the work, led by ...
 Nanotechnology News21 hours ago Sticky Nanoparticles to Fight Ovarian and Uterine Cancer  MedIndia6 days ago A new weapon in the fight against cancer: sticky nanoparticles  World Economic Forum6 days ago Sticky nanoparticles could play vital role in fighting cancers  News-Medical.Net1 week ago
[x]  
Ecancer Medicalscience

uPAR elevated in bronchial tissue of asthma patients

Home » Health » / no comments Few effective treatments have been approved to treat ovarian cancer, the deadliest of all cancers affecting the female reproductive system. Now, new research from The Wistar Institute demonstrates how a drug ...
 HealthMediciNet.com4 days ago The bizarre rise of SCROTOX: Men are paying nearly £3,000 to have Botox in their private parts  HealthMediciNet.com3 days ago Anti-tumour immunity identified with new ovarian cancer treatment strategy  Ecancer Medicalscience5 days ago New Ovarian Cancer Treatment Strategy Identified  MedIndia1 week ago

‘Contraceptives reduce ovarian cancer deaths’

Widespread use of oral contraceptives is driving the fall in the number of deaths from ovarian cancer worldwide, according to a new study published on Tuesday. Deaths from ovarian cancer fell world-wide between 2002 and 2012 and are predicted to continue to ...
 Asian Age3 weeks ago Contraceptive pills driving fall in ovarian cancer deaths  Business Standard3 weeks ago

Discovery of ovarian cancer target paves way for new treatment

A team of researchers has brought fresh hope in the form of a new treatment target for ovarian cancer aka "the silent killer."Researchers at Cold Spring Harbor Laboratory arrived at "new insights into signalling events that underlie metastasis in ...
 Business Standard2 months ago
Freshnews.com

FDA Gives Niraparib Fast Track Designation for Ovarian Cancer

Mary Lynne Hedley, PhD Niraparib has been granted a fast track designation by the FDA as a treatment for women with recurrent platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer, the company developing the PARP inhibitor, ...
 Targeted Oncology1 week ago SELLAS Life Sciences Group Receives FDA Fast Track Designation Of Galinpepimut-S For The Treatment Of Malignant Pleural Mesothelioma  BioSpace1 week ago SELLAS„¢ Life Sciences Receives FDA Fast Track Designation of Galinpepimut-S for the Treatment of Malignant Pleural Mesothelioma  TickerTech.com1 week ago SELLAS Life Sciences Receives FDA Fast Track Designation of Galinpepimut-S for the Treatment of Malignant Pleural Mesothelioma  PR Newswire1 week ago
[x]  
pharmaphorum

AZ withdraws EU ovarian cancer drug filing

AstraZeneca has withdrawn aEuropean filing for its ovarian cancer drug, cediranib. AZ filed the drug with the European Medicines Agency's CHMP scientific committee in June last year. The Anglo-Swedish company was attempting to get the drug ...
 pharmaphorum5 days ago AstraZeneca pulls European filing for ovarian cancer therapy cediranib  FirstWord Pharma1 week ago AZ withdraws European filing for ovarian cancer therapy  Pharmafile6 days ago

New Guidelines Issued For Ovarian Cancer Treatment As Talcum Powder Lawsuit Filings Continue To Grow

TheProductLawyers.com reports on a recent article by HemOnc Today indicating that new guidelines in the treatment of ovarian cancer have been issued by the Society of Gynecological Oncology. The article states that, Neoadjuvant chemotherapy is ...
 Digital Journal5 days ago Aftermath: A Look At What Happens After Treatment Of Ovarian Cancer, A Disease At The Center Of Talcum Powder Lawsuit Filings  Digital Journal1 week ago Questions To Ask: What To Ask A Doctor About Ovarian Cancer, A Disease At The Center Of Talcum Powder Lawsuit Filings  Digital Journal1 week ago Ovarian Cancer Side Effects: A Look At Multiple Issues Associated With A Disease At The Center Of Talcum Powder Lawsuit Filings  Digital Journal1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - Treatment For Ovarian Cancer
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less